Kim Lagerborg is a PhD candidate in the Biological and Biomedical Science program at Harvard University. Her current focus is on engineering tissue specific adeno-associated virus (AAV) capsid variants for gene therapy applications. In addition to her current work, she also has interests in disease surveillance and host-pathogen interactions. Kim graduated from UCSD with a B.S. in Biochemistry and Cell Biology. There, she worked in the lab of Dr. Mohit Jain developing and utilizing high throughput mass spectrometry methods for small molecule screening across population scale cohorts.
KIM LAGERBORG
